Screening Children at Risk for Retinoblastoma. Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists

Alison Skalet, Dan S. Gombos, Brenda L. Gallie, Jonathan W. Kim, Carol L. Shields, Brian P. Marr, Sharon E. Plon, Patricia Chévez-Barrios

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: To provide a set of surveillance guidelines for children at risk for development of retinoblastoma. Design: Consensus panel. Participants: Expert panel of ophthalmic oncologists, pathologists, and geneticists. Methods: A group of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. The panel included representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referral centers located in various geographic regions who met and discussed screening approaches for retinoblastoma. A patient "at risk" was defined as a person with a family history of retinoblastoma in a parent, sibling, or first- or second-degree relative. Main Outcome Measures: Screening recommendations for children at risk for retinoblastoma. Results: Consensus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at risk for retinoblastoma above the population risk. (2) Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. (3) Genetic counseling and testing clarify the risk for retinoblastoma in children with a family history of the disease. (4) Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. (5) Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia. Conclusions: Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma.

Original languageEnglish (US)
JournalOphthalmology
DOIs
StateAccepted/In press - 2017

Fingerprint

Retinoblastoma
Consensus
Genetic Counseling
Genetic Testing
Oncologists
Pathologists
Siblings
Appointments and Schedules
Referral and Consultation
Anesthesia
Outcome Assessment (Health Care)
Guidelines
Pediatrics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Screening Children at Risk for Retinoblastoma. Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. / Skalet, Alison; Gombos, Dan S.; Gallie, Brenda L.; Kim, Jonathan W.; Shields, Carol L.; Marr, Brian P.; Plon, Sharon E.; Chévez-Barrios, Patricia.

In: Ophthalmology, 2017.

Research output: Contribution to journalArticle

Skalet, Alison ; Gombos, Dan S. ; Gallie, Brenda L. ; Kim, Jonathan W. ; Shields, Carol L. ; Marr, Brian P. ; Plon, Sharon E. ; Chévez-Barrios, Patricia. / Screening Children at Risk for Retinoblastoma. Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. In: Ophthalmology. 2017.
@article{6aa01f4e92844290892753d4006aa6f9,
title = "Screening Children at Risk for Retinoblastoma. Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists",
abstract = "Purpose: To provide a set of surveillance guidelines for children at risk for development of retinoblastoma. Design: Consensus panel. Participants: Expert panel of ophthalmic oncologists, pathologists, and geneticists. Methods: A group of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. The panel included representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referral centers located in various geographic regions who met and discussed screening approaches for retinoblastoma. A patient {"}at risk{"} was defined as a person with a family history of retinoblastoma in a parent, sibling, or first- or second-degree relative. Main Outcome Measures: Screening recommendations for children at risk for retinoblastoma. Results: Consensus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at risk for retinoblastoma above the population risk. (2) Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. (3) Genetic counseling and testing clarify the risk for retinoblastoma in children with a family history of the disease. (4) Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. (5) Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia. Conclusions: Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma.",
author = "Alison Skalet and Gombos, {Dan S.} and Gallie, {Brenda L.} and Kim, {Jonathan W.} and Shields, {Carol L.} and Marr, {Brian P.} and Plon, {Sharon E.} and Patricia Ch{\'e}vez-Barrios",
year = "2017",
doi = "10.1016/j.ophtha.2017.09.001",
language = "English (US)",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Screening Children at Risk for Retinoblastoma. Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists

AU - Skalet, Alison

AU - Gombos, Dan S.

AU - Gallie, Brenda L.

AU - Kim, Jonathan W.

AU - Shields, Carol L.

AU - Marr, Brian P.

AU - Plon, Sharon E.

AU - Chévez-Barrios, Patricia

PY - 2017

Y1 - 2017

N2 - Purpose: To provide a set of surveillance guidelines for children at risk for development of retinoblastoma. Design: Consensus panel. Participants: Expert panel of ophthalmic oncologists, pathologists, and geneticists. Methods: A group of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. The panel included representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referral centers located in various geographic regions who met and discussed screening approaches for retinoblastoma. A patient "at risk" was defined as a person with a family history of retinoblastoma in a parent, sibling, or first- or second-degree relative. Main Outcome Measures: Screening recommendations for children at risk for retinoblastoma. Results: Consensus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at risk for retinoblastoma above the population risk. (2) Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. (3) Genetic counseling and testing clarify the risk for retinoblastoma in children with a family history of the disease. (4) Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. (5) Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia. Conclusions: Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma.

AB - Purpose: To provide a set of surveillance guidelines for children at risk for development of retinoblastoma. Design: Consensus panel. Participants: Expert panel of ophthalmic oncologists, pathologists, and geneticists. Methods: A group of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics (AAP) was convened. The panel included representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referral centers located in various geographic regions who met and discussed screening approaches for retinoblastoma. A patient "at risk" was defined as a person with a family history of retinoblastoma in a parent, sibling, or first- or second-degree relative. Main Outcome Measures: Screening recommendations for children at risk for retinoblastoma. Results: Consensus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at risk for retinoblastoma above the population risk. (2) Frequency of examinations is adjusted on the basis of expected risk for RB1 mutation. (3) Genetic counseling and testing clarify the risk for retinoblastoma in children with a family history of the disease. (4) Examination schedules are stratified on the basis of high-, intermediate-, and low-risk children. (5) Children at high risk for retinoblastoma require more frequent screening, which may preferentially be examinations under anesthesia. Conclusions: Risk stratification including genetic testing and counseling serves as the basis for screening of children at elevated risk for development of retinoblastoma.

UR - http://www.scopus.com/inward/record.url?scp=85031786856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031786856&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2017.09.001

DO - 10.1016/j.ophtha.2017.09.001

M3 - Article

C2 - 29056300

AN - SCOPUS:85031786856

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

ER -